1.
Global Strategy For the Diagnosis, Managemant and Preventingof Chronic Obstructive Pulmonary Disease 2019 Report. http://goldcopd.org/gold-reports/.
2.
Rennard S, Decramer M, Calverley PM, et al. Impact of COPDin North America and Europe in 2000: subjects' perspective ofConfronting COPD International Survey. Eur Respir J 2002; 20:799-805.
3.
Breslin E, van der Schans C, Breukink S, et al. Perception offatigue and quality of life in patients with COPD. Chest 1998;114: 958-64.
4.
Burge PS, Calverley PM, Jones PW, Spencer S, Anderson JA,Maslen TK. Randomised, double blind, placebo controlled studyof fluticasone propionate in patients with moderate to severechronic obstructive pulmonary disease: the ISOLDE trial. BMJ2000; 320: 1297-303.
5.
Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smokingintervention and the use of an inhaled anticholinergicbronchodilator on the rate of decline of FEV1. JAMA 1994; 272:1497-505.
6.
Pauwels RA, Löfdahl CG, Laitinen LA, et al. Long-termtreatment with inhaled budesonide in persons with mild chronicobstructive pulmonary disease who continue smoking. EuropeanRespiratory Society Study on Chronic Obstructive PulmonaryDisease. N Engl J Med 1999; 340: 1948-53.
7.
Vestbo J, Sorensen T, Lange P, Brix A, Torre P, Viskum K. Long-term effect of inhaled budesonide in mild and moderate chronicobstructive pulmonary disease: a randomised controlled trial.Lancet 1999; 353: 1819-23.
8.
Garvey C, Bayles MP, Hamm LF, et al. Pulmonary rehabilitationexercise prescription in chronic obstructive pulmonary disease:Review of selected guidelines: An official statement from theAmerican Association of Cardiovascular and PulmonaryRehabilitation. J Cardiopulm Rehabil Prev 2016; 36: 75-83.
9.
Sharma S, Sharma P. Prevalence of dyspnea and its associatedfactors in patients with chronic obstructive pulmonary disease.Indian J Respiratory Care 2019; 8: 36-41.
10.
Liu Y, Pleasants RA, Croft JB, et al. Smoking duration, respiratorysymptoms, and COPD in adults aged ≥45 years with a smokinghistory. International journal of chronic obstructive pulmonarydisease 2015; 10: 1409-16.
11.
Rosi E, Scano G. Cigarette Smoking and Dyspnea Perception.Tob Induc Dis 2004; 2: 3-5.
12.
Sanchez FF, Faganello MM, Tanni SE, Lucheta PA, Padovani CR,Godoy I. Relationship between disease severity and quality of lifein patients with chronicobstructive pulmonary disease. Braz JMed Biol Res 2008; 41: 860-5.
13.
Lin FJ, Pickard AS, Krishnan JA. et al. Measuring health-related quality of life in chronic obstructive pulmonary disease:properties of the EQ-5D-5L and PROMIS-43 short form. BMCMed Res Methodol 2014; 14: 78.
14.
Yılmaz CK, Kapucu S. The effect of progressive relaxationexercises on fatigue and sleep quality in ındividuals with COPD.Holist Nurs Pract 2017; 31: 369-77.
15.
Grant S, Aitchison T, Henderson EA. A comparison of thereproducibility and the sensitivity to change of visual analoguescales, Borg scales, and Likert scales in normal subjects duringsubmaximal exercise. Chest 1999; 116: 1208-17.
16.
Collop N. Sleep and sleep disorders in chronic obstructivepulmonary disease. Respiration 2010; 80: 78-86.
17.
Mohsenin H. Sleep in chronic obstructive pulmonary disease.Semin Respir Crit Care Med 2005; 26: 109-16.
18.
Stege G, Vos PJ, van den Elshout FJ, Richard Dekhuijzen PN, vande Ven MJ, Heijdra YF. Sleep, hypnotics and chronic obstructivepulmonary disease. Respir Med 2008; 102: 801-14.
19.
Douglas NJ, Flenley DC. Breathing during sleep in patients withobstructive lung disease. Am Rev Respir Dis 1990; 141: 1055-70.
20.
Klink ME, Dodge R, Quan SF. The relation of sleep complaints torespiratory symptoms in a general population. Chest 1994; 105:151-4.
21.
Seyedi Chegeni P, Gholami M, Azargoon A, Hossein PourAH, Birjandi M, Norollahi H. The effect of progressive musclerelaxation on the management of fatigue and quality of sleepin patients with chronic obstructive pulmonary disease: Arandomized controlled clinical trial. Complement Ther ClinPract 2018; 31: 64-70.
22.
Akgün Şahin Z, Dayapoğlu N. Effect of progressive relaxationexercises on fatigue and sleep quality in patients with chronicobstructive lung disease (COPD). Complement Ther Clin Pract2015; 21: 277-81.